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A main goal of revascularization in patients with chronic
ischemic cardiomyopathy is to improve global left ven-
tricular (LV) function. This study aimed to verify whether
it is possible to predict an increase in LV ejection fraction
(EF) after revascularization on the basis of the extent of
LV asynergy, myocardial viability, and revascularization
completeness. We studied 77 patients with chronic LV
ischemic dysfunction using baseline resting and nitrate-
enhanced technetium-99m sestamibi single-photon
emission computed tomography. Regional wall motion
and global LVEF were assessed with echocardiography
before and after revascularization, which was complete
in 51 patients and incomplete in 26. The number of
viable asynergic segments included in revascularized
coronary artery territories was the strongest predictor of
significant (>5 EF U) functional improvement in univar-
iate discriminant analysis. According to multivariate
stepwise discriminant analysis, this parameter, together
with the number of baseline asynergic segments, al-
lowed the detection of patients with significant LVEF
improvement with 75% accuracy. With use of a multi-
variate regression model, including the 2 mentioned
variables, the measure of postrevascularization LVEF
increase could be accurately quantified (R2 0.43, p
<0.000001). In conclusion, this study suggests that the
severity of baseline asynergy, the extent of myocardial
viability, and the completeness of revascularization are
the main determinants of postrevascularization func-
tional recovery in patients with LV ischemic dysfunction,
and that on the basis of these variables it is possible to
predict the measure of LVEF increase. 2002 by Ex-
cerpta Medica, Inc.
(Am J Cardiol 2002;89:1369–1373)
V iable dysfunctional myocardium is expected torecover after coronary revascularization.1,2
Therefore, imaging methods that detect myocardial
viability are currently used in patients with chronic
coronary artery disease and left ventricular (LV) dys-
function to orient the therapeutic choices.3–9 In these
patients, the goal of treatment is to improve global LV
function, and possibly heart failure symptoms and
prognosis.2,10–13 Thus, it would be important to pre-
dict the functional gain in the individual patient. A
relation exists between extent of viable myocardium
and improvement in global LV ejection fraction
(EF).4,8,9,12,14–17 However, other variables should be
considered, such as baseline extent of asynergy,
amount of viable myocardium within the dysfunc-
tional area, coronary artery status, and feasibility of a
complete revascularization. Few data exist on the abil-
ity of viability imaging to quantify the degree of
global functional improvement that should be ex-
pected. The aim of the SEstaMIbi with Nitrate Ad-
ministration To predict the Outcome of Revascular-
ization (SEMINATOR) study was to evaluate patients
with chronic coronary artery disease and moderate-to-
severe LV dysfunction submitted to the best possible
revascularization procedure on the basis of their cor-
onary artery status in order to identify which param-
eter best predicts the achievement and extent of global
LV functional improvement.
METHODS
Patient population: Patients were selected accord-
ing to the following criteria: diagnosis of chronic
coronary artery disease confirmed by coronary an-
giography, known LV dysfunction with EF 40%,
presence of clear regional wall motion abnormality,
scheduled revascularization procedure, and willing-
ness to participate in the study. Exclusion criteria were
recent myocardial infarction or unstable angina, heart
disease other than coronary artery disease, and history
of prior revascularization. The study cohort included
77 patients (70 men and 7 women, mean age 61  11
years).
Study protocol: All patients underwent baseline
resting and nitrate technetium-99m sestamibi (sesta-
mibi) single-photon emission computed tomography
(SPECT) to define myocardial viability and 2-dimen-
sional echocardiography to assess LVEF. The refer-
ring physician decided the modality and the complete-
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ness of the revascularization procedure. At least 3
months later, a follow-up control using 2-dimensional
echocardiography was performed to assess changes in
LVEF. Nitrates and -adrenergic blocking agents
were withdrawn 48 hours before all tests. The ethics
committees of our institutions approved the study
protocol and informed consent was obtained from
each patient.
Functional evaluation: Echocardiograms were reg-
istered with the patients lying in the left lateral decu-
bitus position using commercially available echocar-
diographic equipment. Multiple views were obtained
for each study and recorded on videotape for off-line
analysis. Images were evaluated by 2 experienced
observers, unaware of the clinical, angiographic, and
scintigraphic data, and of the acquisition sequence.
The left ventricle was divided into 13 segments,7 and
wall motion and thickening of each segment were
scored as follows: 1  normal, 2  hypokinesia, 3 
akinesia, and 4  dyskinesia.7 Discrepancies were
resolved by consensus. For LVEF calculation, the
biplane Simpson’s method was applied on 3 consec-
utive cardiac cycles examined with the apical 4-cham-
ber view and the mean of the measured values was
used.18 Improvement in LVEF after revascularization
was arbitrarily defined as an increase 5 EF units in
the follow-up compared with the baseline value.12
Sestamibi SPECT: The protocol included 2 separate
studies, 1 after tracer injection at rest and the other
after tracer administration during nitrate infusion. The
nitrate administration protocol has been previously
described.7 Sestamibi dose was 740 to 925 MBq (20 to
25 mCi) in both instances. SPECT studies were ac-
quired 1 hour later using large field-of-view tomo-
graphic gamma cameras equipped with high-resolu-
tion collimators, and with a 20% window centered on
the 140 keV photopeak of technetium-99m. Image
reconstruction was performed using filtered back pro-
jection. After transaxial reconstruction, the slices were
realigned along the heart axis. For the quantitative
evaluation of SPECT images, count profiles of the
short-axis slices were generated by computer software
and plotted onto a volume-weighted
polar map, which was then divided
into 13 segments, matching with the
echocardiographic segments.19 With
use of an automated procedure, mean
tracer activity of each segment was
calculated. The segment with maxi-
mal activity was normalized to 100
and the activity of the other segments
was expressed as a percentage of the
peak activity segment.19
Criteria for myocardial viability:
The assessment of viability was re-
stricted to the segments with resting
wall motion abnormality (scores 2 to
4) as determined by echocardiogra-
phy. Myocardial viability was con-
sidered present in asynergic seg-
ments with a nitrate-induced activity
increase (expressed in percentage of
baseline activity)10%, and was excluded in the case
of nitrate-induced decrease 10%; if a segment had a
nitrate-induced activity change between 10% of
baseline activity, myocardial viability was defined to
be present on the basis of nitrate activity 65%.13,17,19
Statistical analysis: Variables are expressed as mean
 SD. Continuous variables were compared with the
Student’s t test for paired or independent data, as
appropriate, using the Bonferroni correction in case of
multiple comparisons. Ordinal variables were com-
pared with the nonparametric Mann-Whitney U test.
The comparison of proportion was made with the
Fisher’s exact test. The parameters that best differen-
tiate between patients with and without LVEF in-
crease of 5 EF units after revascularization were
selected using stepwise discriminant analysis. To
identify the optimal thresholds of the selected param-
eters, receiver-operating characteristics curves were
constructed. The relation between amount of LVEF
change (expressed in percentage of the prerevascular-
ization value) and its possible predictors was investi-
gated using stepwise multivariate regression. A p
value 0.05 was considered statistically significant.
RESULTS
Patient characteristics: A history of prior myocar-
dial infarction was registered in 72 patients. The mean
New York Heart Association functional class was 1.8
 0.7. According to coronary angiography, 18 pa-
tients had 1-vessel, 25 had 2-vessel, and 34 had 3-ves-
sel coronary artery disease. Of a total number of 1,001
analyzed segments, 684 showed abnormal wall mo-
tion, with a mean of 8.9  2.9 asynergic segments per
patient. Mean LVEF before revascularization was
30.7  7% (range 15% to 40%). According to base-
line-nitrate sestamibi SPECT, dysfunctional segments
fulfilling the criteria for myocardial viability were
detected in 74 patients, with a mean of 5.2  3.1
viable asynergic segments per patient.
Follow-up control: The revascularization procedure
was coronary artery bypass grafting in 38 patients and
TABLE 1 Comparison of Demographic, Clinical, and Instrumental Findings
Between Patients With and Without Significant EF Improvement After Coronary
Revascularization
EF increase 5 EF Units
(n  40)
EF increase 5 EF
Units (n  37)
Men/women 35/5 35/2
Age (yrs) 60  10 61  12
Prior anterior wall infarct 16 (40%) 17 (46%)
No. of stenotic arteries 2.4  0.7 2  0.8*
New York Heart Association functional class 1.8  0.7 1.7  0.7
EF before revascularization (%) 30.3  7.2 31.2  7.1
Asynergic segments 9.1  2.8 8.6  3.1
Viable asynergic segments 6.1  2.9 4.1  3†
Coronary angioplasty/bypass surgery 16/24 21/16
Complete revascularization 27 (68%) 24 (65%)
No. of revascularized vessels 2.1  0.8 1.5  0.8†
Viable asynergic segments in revascularized
territories
5.7  2.7 2.6  2‡
*p 0.05;†p 0.005; ‡p 0.000005.
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percutaneous transluminal coronary angioplasty in 39.
The revascularization procedure was complete in 51
patients. In the remaining 26 patients, the revascular-
ization procedure could not involve all stenotic ves-
sels, but just 1 of 3 in 7 patients, 1 of 2 in 8 patients,
and 2 of 3 in 11 patients. Perioperative infarction was
excluded on the basis of clinical and enzymatic data in
all patients. Recurrent ischemia was ruled out by clin-
ical observation and negative exercise stress testing
whenever necessary. In the postrevascularization
echocardiographic control, mean LVEF was 36  9%
(range 17% to 55%; p 0.00001 vs before revascu-
larization). A5 EF unit increase was registered in 40
patients (from 30.3  7.2% to 41.5  7.4%, p
0.00001). In the remaining 37 cases,
no significant change was observed in
the postrevascularization value (from
31.2  7.1% to 30.1  7%).
Predictors of LVEF improvement: Pa-
tients with significant LVEF improve-
ment differed from those without
LVEF increase in the number of coro-
nary arteries with significant stenosis,
in the number of viable asynergic seg-
ments, in the number of revascularized
vessels, and above all in the number of
viable asynergic segments included in
revascularized coronary territories (Ta-
ble 1). To define the determinants of
significant LVEF improvement, the fol-
lowing variables were submitted to uni-
variate and to stepwise multivariate dis-
criminant analysis: number of stenotic
vessels, number of asynergic segments,
baseline LVEF, number of viable asyn-
ergic segments, number of vessels sub-
mitted to revascularization, number of
revascularized viable asynergic seg-
ments. Table 2 lists which variables
were significant in univariate discrimi-
nant analysis and the related diagnostic
reliability according to the classifica-
tion matrix. Stepwise discriminant
analysis selected the number of revas-
cularized viable asynergic segments
and the number of asynergic segments
as predictors of significant LVEF improvement (Table
2, Figure 1). The derived function had a very signif-
icant canonical correlation, and its classification ma-
trix achieved 75% sensitivity, 76% specificity, and
75% overall accuracy (Table 2, Figure 1). These 2
variables can be merged in 1 single parameter by
calculating their ratio (number of revascularized via-
ble asynergic segments over number of asynergic seg-
ments). According to the receiver-operating character-
istics curve constructed using this ratio, the optimal
threshold to differentiate between patients with and
without LVEF increase of 5 EF units after revascu-
larization was 0.45, with 75% sensitivity and 87%
specificity (Figure 2).
TABLE 2 Results of Discriminant Analysis for Predicting Significant EF Improvement After Coronary Revascularization
Variables in Univariate Analysis Step F Value p Value
Canonical
Correlation p Value
Classification Matrix
True Positive True Negative
No. of stenotic vessels 5.05 0.03 22 25
Viable asynergic segments 8.6 0.005 21 26
No. of revascularized vessels 11.9 0.001 29 22
Viable asynergic segments in
revascularized territories
31.7 0.000001 22 30
Stepwise discriminant analysis
Viable asynergic segments in
revascularized territories
1 40.3 0.000001
No. of asynergic segments 2 6.8 0.02
Function 0.60 0.000001 30 28
FIGURE 1. Scatterplot showing the relation between number of asynergic segments
and number of revascularized viable asynergic segments in patients with (circles)
versus without (crosses) significant LVEF increase after revascularization. The con-
tinuous line indicates the discriminant function; dashed lines indicate the cutoff val-
ues of the variables as determined by univariate analysis.
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Estimate of LVEF changes: According to stepwise
multiple linear regression, the number of revascular-
ized viable asynergic segments (  0.64, p
0.000001), the prerevascularization LVEF ( 
0.38, p 0.001), and the number of asynergic seg-
ments (  0.35, p 0.005) were the significant
predictors of LVEF changes expressed in percentages
of the prerevascularization value. The coefficient of
determination R2 was 0.43 (p 0.000001). Using the
derived equation, the percent change after revascular-
ization could be predicted with good accuracy (Figure
3).
DISCUSSION
In patients with chronic coronary artery disease
and LV dysfunction, the presence of viable myocar-
dium within asynergic areas is necessary for func-
tional recovery after revascularization. In these pa-
tients, coronary revascularization procedures usually
present a relatively high risk.20 Therefore, care must
be given to identify patients in whom the potential
benefit of revascularization overwhelms the procedure
hazard. Several studies have addressed the relation
between presence of viable myocardium and improve-
ment in global LV function, mostly considering the
increase in LVEF.4,8,9,12,14–17 In general, the larger
the extent of viable myocardium, the higher the like-
lihood of achieving a significant increase in
LVEF.4,8,9,12,14–17 However, the capability of viabil-
ity assessment to predict LVEF changes quantitatively
is not yet established. Furthermore, complete revascu-
larization of all stenotic vessels is not always possible
in the clinical practice and this could affect the degree
of improvement.
According to our results, a significant LVEF in-
crease after revascularization can be accurately pre-
dicted on the basis of the number of viable asynergic
segments included in the territories submitted to re-
vascularization corrected by the total number of asyn-
ergic segments. The univariate discriminant function
model selected the number of viable asynergic seg-
ments included within revascularized territories as the
most significant predictor of LVEF increase. This is
reasonable because it is straightforward that viable
myocardium cannot improve in regional wall motion
or contribute to the increase in global LVEF if not
effectively revascularized. However, different from
what is performed in study protocols, achievement of
complete revascularization is not always possible or
considered desirable in daily clinical practice, partic-
ularly when angioplasty is the chosen approach.21 The
study results suggest a method to predict the likely
change in global LV function taking into account the
planned extent of revascularization. This could be
helpful in deciding between increased complexity and
risk of revascularization and possible achievement of
greater functional gain.
A second important finding of this study is that the
relation between extent of viable asynergic myocar-
dium and postrevascularization functional improve-
ment must be corrected to take into account the base-
line extent of dysfunctional tissue. This means that
although a minimal number of viable segments must
be effectively revascularized, their influence on LVEF
changes is related to the baseline extent of the asyn-
ergic area. The number of viable asynergic segments
submitted to revascularization separates patients with
from those without significant functional recovery, but
discrimination between the 2 groups is clearly im-
proved if the number of asynergic segments is also
considered, as indicated by the line (in Figure 1)
showing the discriminant function. Therefore, the
minimal threshold value of viable asynergic segments
necessary for predicting a significant functional recov-
ery after revascularization must be increased in pa-
tients with larger baseline dysfunction. In practice, the
ratio of the 2 above-mentioned parameters can be
used, obtaining a very good diagnostic reliability.
A third interesting finding is that the expected
LVEF change can be reasonably predicted on the basis
of the number of viable asynergic segments submitted
to revascularization. The stepwise multivariate regres-
sion model selects the number of asynergic segments
and the baseline LVEF value as additional significant
predictors. Although the error of this quantification is
not negligible, this result is interesting for 2 reasons.
First, it demonstrates a direct relation between extent
of myocardial viability and extent of functional im-
provement, with a correlation that is well comparable
to what has been registered using the dobutamine-
induced changes in LVEF.14 Second, in patients with
particularly high operative risk or in whom the revas-
cularization results are uncertain, it would be possible
to quantify the predicted functional recovery, giving
to both the clinician and the patient an additional piece
of information to orient the therapeutic choice. It is
conceivable that a great potential gain in global func-
FIGURE 2. Receiver-operating characteristic curve to identify the
best cutoff of the ratio of number of revascularized viable asyn-
ergic segments over the number of asynergic segments for pre-
dicting significant LVEF improvement after revascularization.
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tion would encourage performing a more aggressive
treatment than the expectation of a borderline signif-
icant increase of 5 EF units.
Some limitations of the study must be considered.
A small number of patients had just moderate LV
impairment. However, the degree of LV dysfunction
of the study cohort is comparable to several other
similar studies.5,8–11,15,16 The criteria used to define
the presence of myocardial viability have been dem-
onstrated to be the most accurate, but a simplified
approach based on the sole assessment of nitrate-
enhanced uptake could probably be equally effec-
tive.17 Finally, it cannot be excluded that a larger
number of patients would have shown LV functional
recovery if the follow-up control had been delayed,22
although the interval of 3 months has been widely
used in reports on viability.5,6,8,12,14
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FIGURE 3. Scatterplot showing the relation between the observed change in LVEF
after revascularization (expressed as percentage of prerevascularization value)
and the corresponding value predicted according to multivariate regression analysis.
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